Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

31 Oct 2014 17:17

RNS Number : 9032V
Vernalis PLC
31 October 2014
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Vernalis plc

 

 

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights

 

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

X

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation:

 

SFM UK Management LLP

4. Full name of shareholder(s) (if different from 3.):

 

Quantum Partners LP

5. Date of the transaction and date on which the threshold is crossed or reached:

 

30 October, 2014

6. Date on which issuer notified:

 

31 October, 2014

7. Threshold(s) that is/are crossed or reached:

 

Crossed below 3%

 

8. Notified details:

A: Voting rights attached to shares

 

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Indirect

Direct

Indirect

Ordinary 1p Shares

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 GB00B3Y5L754

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Expirationdate

Exercise/ConversionPeriod

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

 N/A

N/A

N/A

N/A

 N/A

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Exerciseprice

Expirationdate

Exercise/Conversionperiod

Number of votingrights instrumentrefers to

% of voting rights

 

Contract for

Difference

 N/A

 N/A

 N/A

N/A

Nominal

Delta

 

Below 3%

N/A

 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

N/A

Below 3%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

This statement relates to a Contract for Difference ("CFD") held for the account of Quantum Partners LP, a Cayman Islands exempted limited partnership ("Quantum Partners"). SFM UK Management LLP, a subadvisor to Soros Fund Management LLC, serves as investment manager to Quantum Partners and has been granted investment discretion over portfolio investments, including the CFD, held for the account of Quantum Partners.

 

 

Proxy Voting:

 

10. Name of the proxy holder:

 

N/A

11. Number of voting rights proxy holder will cease to hold:

 

N/A

12. Date on which proxy holder will cease to hold voting rights:

 

 N/A

 

13. Additional information:

 

N/A

14. Contact name:

 

Ian Garland, CEO

15. Contact telephone number:

 

0118 938 0015

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFDMFWFFLSEFS
Date   Source Headline
18th Mar 20161:06 pmRNSHolding(s) in Company
17th Mar 20167:00 amRNSUnaudited interim results for 6 months to 31/12/15
4th Feb 20163:34 pmRNSNotice of Results for Six Months Ended 31/12/2015
19th Jan 20162:36 pmRNSHolding(s) in Company
6th Jan 20167:00 amRNSVernalis Announces Adenosine Antagonist Licensee
31st Dec 20157:00 amRNSTotal Voting Rights
21st Dec 20157:00 amRNSVernalis Announce CCP-07 Single-Dose Study Results
3rd Dec 20155:19 pmRNSLaunch of 2015 Sharesave Plan
2nd Dec 201511:19 amRNSVernalis Results of Annual General Meeting
2nd Dec 20157:00 amRNSAGM Statement
1st Dec 20154:54 pmRNSHolding(s) in Company
23rd Nov 20155:23 pmRNSHolding(s) in Company
4th Nov 20154:34 pmRNSHolding(s) in Company
30th Oct 20157:00 amRNSTotal Voting Rights
28th Oct 20159:00 amRNSNotice of Annual Report and AGM
15th Oct 20153:54 pmRNSDirector Dealing
15th Oct 20152:02 pmRNSHolding(s) in Company
12th Oct 20157:00 amRNSCCP-08 starts 12 month stability testing
8th Oct 20152:19 pmRNSDirector Dealing
2nd Oct 20157:00 amRNSVernalis plc acquires US rights to MOXATAG®
29th Sep 20157:02 amRNSResults announcement for 18 months ended 30/06/15
25th Sep 201511:09 amRNSBlocklisting Interim Review
16th Sep 20155:08 pmRNSHolding(s) in Company
11th Sep 20157:00 amRNSNotice of Results
8th Sep 20157:00 amRNSVernalis plc Launches Tuzistra(TM) XR
20th Aug 20157:00 amRNSVernalis completes investment in NCE development
18th Aug 20157:00 amRNSAppointment of Non-Executive Director
30th Jun 20151:27 pmRNSAppointment of Non-Executive Director
30th Jun 20157:00 amRNSTotal Voting Rights
12th Jun 20154:34 pmRNSHolding(s) in Company
11th Jun 20157:00 amRNSCCP-07 starts 12 month stability testing
6th May 20151:45 pmRNSBlock Listing Six Monthly Review
6th May 201512:30 pmRNSDirector/PDMR Shareholding
1st May 20154:38 pmRNSHolding(s) in Company
1st May 20157:00 amRNSFDA approves NDA for Tuzistra XR
30th Apr 20153:27 pmRNSHolding(s) in Company
23rd Apr 20152:39 pmRNSHolding(s) in Company
7th Apr 20157:00 amRNSVernalis enters into research collaboration
31st Mar 201512:47 pmRNSTotal Voting Rights
6th Mar 20157:00 amRNSVernalis and AKP Achieve Research Milestone
26th Feb 20157:00 amRNSVernalis licenses proprietary ARA technology
18th Feb 201512:51 pmRNSHolding(s) in Company
10th Feb 20157:00 amRNSUnaudited interim results for periods to 31/12/14
5th Feb 20155:53 pmRNSHolding(s) in Company
30th Jan 201511:50 amRNSNotice of Interim Results Period Ended 31 Dec 2014
26th Jan 20151:06 pmRNSHolding(s) in Company
21st Jan 201511:00 amRNSChange of Non-Executive Director
31st Dec 20147:00 amRNSTotal Voting Rights
19th Dec 20147:00 amRNSUpdate on AUY922 development programme
28th Nov 20147:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.